Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

[AMD: Future therapies].

Cohen SY, Girmens JF.

J Fr Ophtalmol. 2011 Sep;34(7):498-501. doi: 10.1016/j.jfo.2011.04.004. Epub 2011 Jun 11. French.

2.

[Future methods of treatment in age related macular degeneration].

Turlea C.

Oftalmologia. 2012;56(1):30-5. Review. Romanian.

PMID:
22888684
3.

Age-related macular degeneration (AMD): pathogenesis and therapy.

Nowak JZ.

Pharmacol Rep. 2006 May-Jun;58(3):353-63. Review.

4.

Genetics of age-related macular degeneration.

Ting AY, Lee TK, MacDonald IM.

Curr Opin Ophthalmol. 2009 Sep;20(5):369-76. doi: 10.1097/ICU.0b013e32832f8016. Review.

PMID:
19587596
5.

New approaches and potential treatments for dry age-related macular degeneration.

Damico FM, Gasparin F, Scolari MR, Pedral LS, Takahashi BS.

Arq Bras Oftalmol. 2012 Jan-Feb;75(1):71-6. Review.

6.

Age-related macular degeneration.

Segato T, Midena E, Blarzino MC.

Aging (Milano). 1993 Jun;5(3):165-76. Review.

PMID:
8399461
7.

Development of typical age-related macular degeneration and polypoidal choroidal vasculopathy in fellow eyes of Japanese patients with exudative age-related macular degeneration.

Ueta T, Iriyama A, Francis J, Takahashi H, Adachi T, Obata R, Inoue Y, Tamaki Y, Yanagi Y.

Am J Ophthalmol. 2008 Jul;146(1):96-101. doi: 10.1016/j.ajo.2008.03.002. Epub 2008 Apr 24.

PMID:
18439567
8.

Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).

Rasmussen H, Chu KW, Campochiaro P, Gehlbach PL, Haller JA, Handa JT, Nguyen QD, Sung JU.

Hum Gene Ther. 2001 Nov 1;12(16):2029-32.

PMID:
11727737
9.

Anti-VEGF agents for age-related macular degeneration.

Ozkiris A.

Expert Opin Ther Pat. 2010 Jan;20(1):103-18. doi: 10.1517/13543770902762885. Review.

PMID:
20021287
10.

[Guidance for the treatment of neovascular age-related macular degeneration (AMD)].

Karska-Basta I, Kubicka-Trzaska A, Oleksy P, Romanowska-Dixon B.

Przegl Lek. 2009;66(11):972-5. Review. Polish.

PMID:
20297641
11.

Immunological factors in the pathogenesis and treatment of age-related macular degeneration.

Kijlstra A, La Heij E, Hendrikse F.

Ocul Immunol Inflamm. 2005 Feb;13(1):3-11. Review.

PMID:
15804763
12.

[Therapeutic innovation in AMD and other retinal diseases].

Girmens JF, Picaud S, Sahel JA.

Rev Prat. 2013 Jan;63(1):68-73. Review. French.

PMID:
23457831
13.

Transplantation of the RPE in AMD.

Binder S, Stanzel BV, Krebs I, Glittenberg C.

Prog Retin Eye Res. 2007 Sep;26(5):516-54. Epub 2007 Mar 6. Review.

PMID:
17532250
14.

Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas.

Dentchev T, Milam AH, Lee VM, Trojanowski JQ, Dunaief JL.

Mol Vis. 2003 May 14;9:184-90.

15.

Photoreceptor loss in age-related macular degeneration.

Curcio CA, Medeiros NE, Millican CL.

Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1236-49.

PMID:
8641827
16.

Maculoplasty for age-related macular degeneration: reengineering Bruch's membrane and the human macula.

Del Priore LV, Tezel TH, Kaplan HJ.

Prog Retin Eye Res. 2006 Nov;25(6):539-62. Epub 2006 Oct 30. Review.

PMID:
17071125
17.

Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.

Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE.

Ophthalmology. 2007 Feb;114(2):253-62.

PMID:
17270675
18.

Age-related macular degeneration: a new viewpoint.

Hamdi HK, Kenney C.

Front Biosci. 2003 May 1;8:e305-14. Review.

PMID:
12700041
20.

New treatments for age-related macular degeneration.

Mittra RA.

Minn Med. 2003 Apr;86(4):40-6.

PMID:
12797657

Supplemental Content

Support Center